HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

R-154716

active metabolite of R-138329; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - R-154716: 1

Experts

1.	Abe, Koji: 1 article (10/2007)
2.	Amemiya, Yoshiya: 1 article (10/2007)
3.	Inaba, Toshimori: 1 article (10/2007)
4.	Kitayama, Ken: 1 article (10/2007)
5.	Nishizawa, Tomohiro: 1 article (10/2007)
6.	Oda, Tomiichiro: 1 article (10/2007)
7.	Ubukata, Naoko: 1 article (10/2007)
8.	Uchiyama, Minoru: 1 article (10/2007)
9.	Wakabayashi, Kenji: 1 article (10/2007)
10.	Yamada, Makiko: 1 article (10/2007)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 10/01/2007 - "In vitro analysis showed that R-154716, a metabolite of R-138329, dramatically inhibited the uptake of [(3)H]COE-labeled HDL in McA-RH 7777 rat hepatoma cells. "

Related Drugs and Biologics

1.	N- (4- (4- tert- butoxycarbonylpiperazin- 1- yl)phenyl)- (2- chloro- 5- nitrophenyl)carboxamide